{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:14:39Z","timestamp":1774908879217,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10147-021-02036-1","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:48:34Z","timestamp":1633654114000},"page":"121-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Large and diffuse ductal carcinoma in situ: potentially lethal subtypes of \u201cpreinvasive\u201d disease"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-8569","authenticated-orcid":false,"given":"Thomas J.","family":"O\u2019Keefe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Harismendy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"2036_CR1","doi-asserted-by":"publisher","unstructured":"Punglia R, Bifolck K, Golshan M et al. (2018) Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS). Jnci Cancer Spectr. https:\/\/doi.org\/10.1093\/jncics\/pky063.","DOI":"10.1093\/jncics\/pky063"},{"key":"2036_CR2","doi-asserted-by":"publisher","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), Correa C, McGale P, Taylor C, Wang Y, Clarke M, et al. (2010) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. https:\/\/doi.org\/10.1093\/jncimonographs\/lgq039.","DOI":"10.1093\/jncimonographs\/lgq039"},{"key":"2036_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-med-050715-104920","volume":"68","author":"AV Barrio","year":"2017","unstructured":"Barrio AV, Van Zee KJ (2017) Controversies in the treatment of ductal carcinoma in situ. Annu Rev Med 68:197\u2013211. https:\/\/doi.org\/10.1146\/annurev-med-050715-104920","journal-title":"Annu Rev Med"},{"key":"2036_CR4","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199306033282201","volume":"328","author":"B Fisher","year":"1993","unstructured":"Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N et al (1993) Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328:1581\u20131586. https:\/\/doi.org\/10.1056\/NEJM199306033282201","journal-title":"N Engl J Med"},{"key":"2036_CR5","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","volume":"31","author":"M Donker","year":"2013","unstructured":"Donker M, Liti\u00e8re S, Werutsky G et al (2013) Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol Off J Am Soc Clin Oncol 31:4054\u20134059. https:\/\/doi.org\/10.1200\/JCO.2013.49.5077","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2036_CR6","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1200\/JCO.2007.12.7969","volume":"26","author":"L Holmberg","year":"2008","unstructured":"Holmberg L, Garmo H, Granstrand B, Ringberg A, Arnesson L-G, Sandelin K et al (2008) Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol Off J Am Soc Clin Oncol 26:1247\u20131252. https:\/\/doi.org\/10.1200\/JCO.2007.12.7969","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2036_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0140-6736(03)13859-7","volume":"362","author":"J Houghton","year":"2003","unstructured":"Houghton J, George WD, Cuzick J et al (2003) Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet Lond Engl 362:95\u2013102. https:\/\/doi.org\/10.1016\/s0140-6736(03)13859-7","journal-title":"Lancet Lond Engl"},{"key":"2036_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","volume":"16","author":"B Fisher","year":"1998","unstructured":"Fisher B, Dignam J, Wolmark N et al (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol Off J Am Soc Clin Oncol 16:441\u2013452. https:\/\/doi.org\/10.1200\/JCO.1998.16.2.441","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2036_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","volume":"12","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, Sestak I, Pinder SE et al (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial. Lancet Oncol 12:21\u201329. https:\/\/doi.org\/10.1016\/S1470-2045(10)70266-7","journal-title":"Lancet Oncol"},{"key":"2036_CR10","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1245\/s10434-009-0635-x","volume":"16","author":"KP McGuire","year":"2009","unstructured":"McGuire KP, Santillan AA, Kaur P et al (2009) Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol 16:2682\u20132690. https:\/\/doi.org\/10.1245\/s10434-009-0635-x","journal-title":"Ann Surg Oncol"},{"issue":"31A","key":"2036_CR11","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/0959-8049(95)00283-o","volume":"1995","author":"MJ Silverstein","year":"1990","unstructured":"Silverstein MJ, Barth A, Poller DN et al (1990) Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer Oxf Engl 1995(31A):1425\u20131427. https:\/\/doi.org\/10.1016\/0959-8049(95)00283-o","journal-title":"Eur J Cancer Oxf Engl"},{"key":"2036_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3322\/caac.21321","volume":"65","author":"EM Ward","year":"2015","unstructured":"Ward EM, DeSantis CE, Lin CC et al (2015) Cancer statistics: breast cancer in situ. CA Cancer J Clin 65:481\u2013495. https:\/\/doi.org\/10.3322\/caac.21321","journal-title":"CA Cancer J Clin"},{"key":"2036_CR13","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ (1988) A class of $k$-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141\u20131154. https:\/\/doi.org\/10.1214\/aos\/1176350951","journal-title":"Ann Stat"},{"key":"2036_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/pan\/mpl013","volume":"15","author":"DE Ho","year":"2007","unstructured":"Ho DE, Imai K, King G, Stuart EA (2007) Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Polit Anal 15:199\u2013236. https:\/\/doi.org\/10.1093\/pan\/mpl013","journal-title":"Polit Anal"},{"key":"2036_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1072-7515(97)00153-1","volume":"186","author":"M Morrow","year":"1998","unstructured":"Morrow M, Bucci C, Rademaker A (1998) Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg 186:269\u2013274. https:\/\/doi.org\/10.1016\/S1072-7515(97)00153-1","journal-title":"J Am Coll Surg"},{"key":"2036_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jso.22020","volume":"105","author":"I Schmale","year":"2012","unstructured":"Schmale I, Liu S, Rayhanabad J et al (2012) Ductal carcinoma in situ (DCIS) of the breast: perspectives on biology and controversies in current management. J Surg Oncol 105:212\u2013220. https:\/\/doi.org\/10.1002\/jso.22020","journal-title":"J Surg Oncol"},{"key":"2036_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11912-019-0777-3","volume":"21","author":"LJ Solin","year":"2019","unstructured":"Solin LJ (2019) Management of ductal carcinoma in situ (dcis) of the breast: present approaches and future directions. Curr Oncol Rep 21:33. https:\/\/doi.org\/10.1007\/s11912-019-0777-3","journal-title":"Curr Oncol Rep"},{"key":"2036_CR18","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","volume":"1","author":"SA Narod","year":"2015","unstructured":"Narod SA, Iqbal J, Giannakeas V et al (2015) Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1:888\u2013896. https:\/\/doi.org\/10.1001\/jamaoncol.2015.2510","journal-title":"JAMA Oncol"},{"key":"2036_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41523-021-00267-z","volume":"7","author":"AC Glencer","year":"2021","unstructured":"Glencer AC, Wong JM, Hylton NM et al (2021) Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection. Npj Breast Cancer 7:59. https:\/\/doi.org\/10.1038\/s41523-021-00267-z","journal-title":"Npj Breast Cancer"},{"key":"2036_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.amjsurg.2007.08.057","volume":"196","author":"M Yi","year":"2008","unstructured":"Yi M, Krishnamurthy S, Kuerer HM et al (2008) Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 196:81\u201387. https:\/\/doi.org\/10.1016\/j.amjsurg.2007.08.057","journal-title":"Am J Surg"},{"key":"2036_CR21","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/sj.bjc.6602102","volume":"91","author":"JM Satagopan","year":"2004","unstructured":"Satagopan JM, Ben-Porat L, Berwick M et al (2004) A note on competing risks in survival data analysis. Br J Cancer 91:1229\u20131235. https:\/\/doi.org\/10.1038\/sj.bjc.6602102","journal-title":"Br J Cancer"},{"key":"2036_CR22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10549-020-05733-z","volume":"182","author":"TJ O\u2019Keefe","year":"2020","unstructured":"O\u2019Keefe TJ, Wallace AM (2020) Surveillance, Epidemiology, and End Results program underestimates breast cancer-specific mortality after ductal carcinoma in situ diagnosis. Breast Cancer Res Treat 182:761\u2013762. https:\/\/doi.org\/10.1007\/s10549-020-05733-z","journal-title":"Breast Cancer Res Treat"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-021-02036-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-021-02036-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-021-02036-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T17:08:16Z","timestamp":1641402496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-021-02036-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2036"],"URL":"https:\/\/doi.org\/10.1007\/s10147-021-02036-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.17.20196931","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]},"assertion":[{"value":"26 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interst"}},{"value":"Deferred by UCSD IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent could not be obtained due to the use of public, de-identified data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Unable to obtain due to use of public, deidentified data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Unable to obtain due to use of public, deidentified data.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal participate"}}]}}